https://www.truescoopnews.com/bharat-biotechs-covaxin

Find whatever's trending in Punjab, India and the world on True Scoop News. From Breaking news to analysis of the trending topics, True Scoop covers it all

bharat-biotechs-covaxin

DCGI has also approved Zayed Cadila's Zycov D vaccine for emergency use for children above 12 years of age.

Bharat Biotech's Covaxin gets a nod for emergency use in children aged 6-12 years

The executive director of WHO Health Emergencies Programme said that the body wants all countries to recognise Emergency Use Listing (EUL) vaccines.

WHO says “cannot cut corners” when asked about Covaxin’s approval

Bharat Biotech said, “The company has submitted 90 percent of the documents required for WHO’s authorization for Emergency Use Listing.”

Bharat Biotech confident of WHO’s nod for Covaxin amid reports of travel ban

Over 19.33 crore vaccine doses have been administered in the country under the inoculation drive against COVID-19, the statement said.

India reports 3,55,102 recoveries in 24 hrs, only 8 states have over 1L active caseload

The expert panel suggested the phase two and three trials which now will be carried out on 525 healthy volunteers.

Covaxin receives green flag for Phase 2/3 clinical trials on 2-18 age group

Vardhan and Goel received Bharat Biotech's Covaxin and paid Rs 250 each for the doses.

'Those who can afford should get vaccinated in pvt hospitals', says Health Minister

This is a major relief for India which has the second highest number of infections in the world, after the US. The Central government plans to vaccinate nearly 30 crore people in the first phase of drive in the next six to eight months.

News